Neurosoft Bioelectronics is proud to announce that it has received ISO 13485:2016 certification by TÜV SÜD for its Quality Management System. This is a major milestone as it brings the company one step closer to clinical studies and regulatory approval for its innovative soft implantable electrode and BCI systems.

A big congratulations to the entire team for their commitment to quality and hard work. With this certification, Neurosoft Bioelectronics is one step closer to its goal of providing monitoring and diagnostics for drug-resistant epilepsy patients as well as patients suffering from brain tumors, and to advance future therapies in development, starting from the treatment of Severe Tinnitus through closed-loop cortical neuro-stimulation.

Read the full press release here.